About QTMM share price and its peers Stephen Squires

New Post Public Reply Private Reply Replies (0) Message Board
solartech
563
About QTMM share price and its peers


Stephen Squires (past Shareholder Update): "Without revenue share price is meaningless, current share price does not reflect the company's value, only sustainable revenue will".

Which potential start up junior does not see its share price lingering at 2 cents for years while other companies with no potential of growth see their share price dwindling down to $0.00000001. Market Makers reward only companies succeed in achieving sustainable revenue.

All of us have spent around 15 years in school and college and incurred quarter million dollar in expenses but generated no income. We were planting seeds for the future. So did Stephen Squires, the seeds he planted in the past 12 years are emerging with juicy fruits.

Only those with patience and endurance will harvest the rare juicy fruits that comes only once in one's life time, achieve an early retirement and enjoy a longer life.

Cats and dogs will have their days, QTMM share price history proved that only news of revenue did and will cause share price surging or soaring. Subscribers for the QDX HealthID App are enrolling in, the company is in the REVENUE PHASE. When the time is ripe the rocket will be launched.



The following junior companies are involved in either one of Quantum dot applications, Blockchain, Anti-counterfeiting or COVID-19 remedy. QMC involves in all of Quantum dot applications, Blockchain, Anti-counterfeiting and COVID-19 remedy.

Patient shareholders of those companies who loaded up at 2 cents and had the patience to wait it out will be very rich and will achieve an early retirement.

SONA.CA share outstanding: 60,778,028

1) SONA.CA: https://bigcharts.marketwatch.com/advchart/fr...p;state=10

https://stockcharts.com/h-sc/ui?s=SONA.CA&...1082121508


GNBT.OTC share outstanding: 79,848,471

2) GNBT: https://bigcharts.marketwatch.com/advchart/fr...p;state=10

https://stockcharts.com/h-sc/ui?s=GNBT&p=...6917193450


DECN.OTC share outstanding: 300,623,608

3) DECN: https://bigcharts.marketwatch.com/advchart/fr...p;state=10

https://stockcharts.com/h-sc/ui?s=DECN&p=...1374977044


DM.TSXV share outstanding: 259,016,361

4) DM: https://bigcharts.marketwatch.com/advchart/fr...p;state=10

https://stockcharts.com/h-sc/ui?s=DM.V&p=...0466724109


MIR.TSXV share outstanding: 658,364,320

5) MIR: https://bigcharts.marketwatch.com/advchart/fr...p;state=10

https://stockcharts.com/h-sc/ui?s=MIR.V&p...6045510877


RVV.CA share outstanding: 189,408,777

6) RVV.CA: https://bigcharts.marketwatch.com/advchart/fr...p;state=10

https://stockcharts.com/h-sc/ui?s=RVV.CA&...2467881018


QTMM.OTC share outstanding: 683,213,592

7) QTMM: https://bigcharts.marketwatch.com/advchart/fr...p;state=10

QTMM weekly
https://stockcharts.com/h-sc/ui?s=QTMM&p=...3745155094


Future share price projection

American population: 428 million
If only 50% of the population will subscribe to QDX HealthID (an extremely conservative estimate), there will be 214 million subscribers.

Each App cost subscriber $2.69. For each test, QDX HealthID Inc will receive $2 from its test kit / test service partner, so revenue from each subscriber is around $4.

214 million subscribers x $4 = $856 million (excluding numerous re-testing)

Gross Revenue: $856 million
Cost of Revenue (assume to be 30% of Gross Revenue): $257 million
Net Revenue (profit):$600 million
Administrative and Operating Cost: $7 million (from past financials)
Net Earnings: $593 million
Share outstanding at A/S limit: 750 million
Earnings per share: $0.80

P/E Ratio_______Projected Share Price
===============================
4______________$3.20
5______________$4.00
6______________$4.80
7______________$5.60


When the time is ripe, the rocket will be launched


1350084621_qblweDoor_of_opportunity.jpg


1982810321_Destiny_in_Space.jpg


















Quantum Materials Corp. (QTMM) Stock Research Links

QTMM Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Hyzon Motors Plans Delisting from Nasdaq—What This Means

Updated Category News Views 195

Hyzon Motors Announces Delisting from Nasdaq Hyzon Motors Inc. is making a significant shift regarding its stock trading status. This U.S. company, known for its commitment to high-performance hydrogen fuel cell technology, has decided to inform Nasdaq Stock Market of its intent to delist its Class A common stock and publicly traded warrants. This move comes as part of...

Continue Reading
Unlock the Potential of Crypto Staking with Keynode.net

Updated Category News Views 113

Your Gateway to High Returns in Crypto Staking As the digital currency landscape continues to expand, platforms like Keynode.net are leading the charge in offering unprecedented opportunities for investors. For those seeking impressive annual percentage yields (APY) through crypto staking, Keynode.net has emerged as a premier choice. Its user-friendly interface, robust...

Continue Reading
Critical Updates for Rocket Pharmaceuticals Investors Amid Lawsuit

Updated Category News Views 263

Overview of the Class Action Lawsuit Against Rocket Pharmaceuticals Pomerantz LLP has initiated a class action lawsuit against Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) highlighting various concerns regarding the company's business practices. Investors who have suffered losses during the stipulated Class Period should take note of this unfolding situation. Key Details...

Continue Reading
Revitalizing Economic Growth at the 23rd SMDO Conference

Updated Category News Views 141

Revitalizing Economic Growth at the 23rd SMDO Conference The 23rd Annual South Metro Development Outlook (SMDO25) Conference stands as a pivotal forum for industry leaders, policymakers, and community stakeholders. It is designed to foster collaboration and tackle some of the most pressing issues faced by the region today. Set against the backdrop of changing federal...

Continue Reading
SciBase's Strong Growth in Q1 2025: Key Highlights and Future

Updated Category News Views 222

Strong First Quarter Results for SciBase In the recent interim report, SciBase has showcased an impressive performance for the first quarter of 2025. The medical technology company, renowned for its innovative dermatological solutions, recorded net sales of TSEK 8,856, marking a remarkable increase of 46% from the previous year’s figures. Financial Performance Overview...

Continue Reading